Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Global X Genomics & Biotechnology ETF - USD
Similar ETFs
Trading data
GNOM performance and flow charts
Performance
Flows
Historic performance and flows
Data as of March 10, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | -1.95% | -2.77% | -0.14% | +31.18% | -2.20% | -49.04% |
| Flows | - | -$4M | -$2M | -$19M | -$115M | +$13M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +23.39% | +30.06% | +28.58% | +33.54% |
Max drawdown | -10.49% | -22.14% | -46.50% | -72.17% |
Max drawdown duration | 47d | 113d | 1030d | 1713d |
Time to recover | N/A | 92d | N/A | N/A |
Replication quality
Data as of February 27, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
Exposure
Data as of January 31, 2026Countries
Sectors
Diversification
Total weight of top 15 holdings out of 48
Top 15 Holdings
Characteristics
The Global X Genomics & Biotechnology ETF - USD is built to track the Solactive Genomics Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly).
This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Provider | Global X |
| N° of holdings | 48 |
| Replication method | Direct (Physical) |
| Asset class | Equities |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | April 5, 2019 |
| ESG | No |
What type of ETF is GNOM?
GNOM is a Passive ETF that provides exposure to Equity assets. It is managed by Global X.
What index does GNOM track?
GNOM tracks the Solactive Genomics Index - USD, aiming to replicate its performance through full replication.
What does GNOM invest in?
This ETF provides exposure to Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of GNOM?
The total expense ratio (TER) of GNOM is 0.5%, representing the annual fee charged by the fund manager.
When was GNOM launched?
GNOM was launched on April 5, 2019, marking its entry into the ETF market.
Who is the issuer of GNOM?
GNOM is issued by Global X.
What is the AUM of GNOM?
As of March 10, 2026, GNOM manages $49.78 M, reflecting the total assets held in the fund.
How has GNOM performed recently?
As of March 10, 2026, GNOM delivered a return of -1.95% over the past month (1M performance), -2.77% over the past three months (3M), and -0.14% year-to-date (YTD).
Does GNOM pay dividends?
As of March 10, 2026, GNOM has a trailing 12-month distribution yield of 1.37%.
How many holdings are in GNOM
As of January 31, 2026, GNOM holds 48 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is GNOM?
As of January 31, 2026, GNOM holds 48 securities, with 63.95% of its assets concentrated in its top 15 holdings.
What are the top holdings of GNOM?
As of January 31, 2026, GNOM holds a portfolio of 48 underlyings, with its largest positions including MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does GNOM invest in?
As of January 31, 2026, GNOM has its largest geographic exposures in USA.
What sectors or themes does GNOM focus on?
As of January 31, 2026, GNOM is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.
What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).
What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).
What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).
Browse all educational columns
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
